Press releases
Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.
| RegulatoryRead more
Glycorex Transplantation AB (publ): Interim Report January – September 2023
| RegulatoryRead more
Glycorex Transplantation AB (publ): Interim Report January – June 2023
| RegulatoryRead more
Glycorex appoints Lars Juliusson as Business Development Manager Transfusion
| Non-regulatoryRead more
Glycorex Transplantation AB (publ): Interim Report January – March 2023
| RegulatoryRead more
Annual Report 2022 Glycorex Transplantation AB (publ)
| RegulatoryRead more
Published study from the US shows promising results on the use of Glycosorb® ABO to provide low-titer group O whole blood
| Non-regulatoryRead more
Year-end Report 2022
| RegulatoryRead more
The first blood group incompatible kidney transplant using Glycosorb® ABO performed in South Africa
| Non-regulatoryRead more
Glycorex strengthens the organization to place additional force behind the growth strategy Going 4 Growth
| Non-regulatoryRead more
Glycorex Transplantation AB (GTAB B): Interim report January – September 2022
| RegulatoryRead more
Glycorex Transplantation (GTAB B): Glycosorb[®] ABO used at the largest heart transplant center in Germany
| Non-regulatoryRead more
News
Exhibition overview
25 March 2023 – 33. Münsteraner Symposium Nierentransplantation, Germany
24-26 May 2023 – MESOT (Middle East Society For Organ Transplantation), Turkey
1-3 June 2023 – 14th World Congress of the International Society for Apheresis (ISFA), Germany
3-7 June 2023 – ATC (American Transplant Congress), USA
17-21 June 2023 – ISBT (International Society of Blood Transfusion), Sweden
17-20 September 2023 – ESOT (European Society for Organ Transplantation), Greece
26-28 October 2023 – DTG 2023 (Annual Meeting of the German Transplantation Society), Germany
Johan Lavén, CEO presenting Glycorex Transplantation on Aktiedagen (Aktiespararna) September 19 2023.
Geert Nygaard, CEO presenting Glycorex Transplantation on Aktiedagen (Aktiespararna) januari 31 2022.
The presentation on Youtube >>
Pontus Nobréus, CEO presenting Glycorex Transplantation on Redeye Growth Day june 2.
Presentationen >>
Download the presentationen >>
Pontus Nobréus, CEO presenting Glycorex Transplantation BioStock Life Science Spring Summit on May 26
https://youtu.be/5fpTsNENiO8
Glycorex Transplantation is a proud collaborator with The Hospital Clínic de Barcelona in Spain. It recently became the first hospital in Spain to carry out more than 1,000 living donor kidney transplants. To celebrate this milestone, a campaign called “A thousand transplants, a thousand stories” was launched to increase public awareness and encourage living donor kidney donations. https://www.clinicbarcelona.org/en/news/the-hospital-clinic-the-first-hospital-in-spain-to-carry-out-1-000-living-donor-kidney-transplants
REDEYE GROWTH DAY
Pontus Nobréus, CEO of Glycorex Transplantation will present at the Redeye Growth Day on June 2, 2021 at 08:50 CET.
Link to live streaming: https://www.redeye.se/events/808637/redeye-growth-day-2021
Glycorex Transplantation participates in the BioStock Life Science Spring Summit 2021. CEO Pontus Nobréus will present the company at the BioStock Life Science Spring Summit on May 26-27. For more information please visit: www.summit.biostock.se
Tomorrow, april 29th, Dr Guirado from Spain will discuss ABO incompatible kidney transplantations in a live Zoom seminar, arranged by our distributor in Mexcio, Ryse Médica and Sociedad Mexicana De Transplantes.
Scheelevägen 27 | SE-223 63 Lund, Sweden
Phone: +46 46 286 52 30 | Fax: +46 46-286 52 39
E-mail: info@glycorex.com
Org.nr: 556519-7372
© 2022 Glycorex Transplantation AB. Registered office in Lund, Sweden . All rights reserved.